News

Danaher to acquire Abcam for $24.00 per Share

Cambridge, UK / Waltham, MA, August 28, 2023 – Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced today that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (‘Danaher’) will acquire all of the outstanding shares of Abcam for $24.00 per share in cash (the ‘Transaction’). 


The Transaction has been unanimously approved and recommended by the Abcam Board of Directors and unanimously approved by the Danaher Board of Directors. 

Read more

TechBio innovator Etcembly reveals world’s first generative AI-designed bispecific T cell engager with picomolar affinity

Oxford, UK - British techbio innovator Etcembly is coming out of stealth mode, kickstarting the next generation of immunotherapies with a pipeline of best-in-class T cell receptor (TCR) therapeutics designed using generative AI.


The company’s lead therapeutic programme, ETC-101, is the world’s first AI-designed bispecific T cell engager. It targets PRAME, a validated antigen present in many cancers but absent from healthy tissue.

Read more

Babraham Research Campus and Equiem team up to elevate life science community experience

Babraham Research Campus and Global proptech leader Equiem have announced a partnership that will provide an enhanced experience for the Campus’s life science community in Cambridge. The collaboration will create one central communication hub that will add value to the service offering for Babraham Research Campus companies and enhance the overall experience of life on Campus.

Read more

With a focus on mentoring, BioMed Realty's Colleen O'Connor authors article to share lessons learned in life sciences real estate

As part of The Business Journals’ Bizwomen feature, BioMed Realty’s Colleen O'Connor authored an article to share insights and advice from her successful career in life sciences real estate.

Read more

Unispace Group strengthens its life sciences offering by acquiring Bulb

London, 17 August 2023 – Global life sciences strategy, design, and construction firm, Unispace Life Sciences, has acquired UK laboratory and office fit-out specialist Bulb. This is the second life sciences design company the business welcomes in less than two years, after attaining BioPharma Engineering (BPE) in Cork, Ireland in 2022.

Read more

ARECOR TO COLLABORATE WITH TOP 10 GLOBAL PHARMACEUTICAL COMPANY

Arecor Therapeutics plc

(“Arecor” or the “Group”)


ARECOR TO COLLABORATE WITH TOP 10 GLOBAL PHARMACEUTICAL COMPANY


Arecor expands its global partnerships through collaboration to develop an enhanced antibody formulation


Cambridge, UK, 17 August 2023: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that it has signed an agreement with a top 10 pharmaceutical company to develop an enhanced antibody formulation for one of its investigational drugs.

Read more

MedFlow Clinical joins One Nucleus

Hello to all ON members,


We are thrilled to announce that MedFlow Clinical has officially joined the prestigious ranks of One Nucleus.


As a new member of this esteemed network, we eagerly anticipate the remarkable opportunities that lie ahead.


Our team is excited to engage with the vibrant community of Life Science professionals within One Nucleus, and we are eagerly looking forward to forging meaningful connections, sharing insights, and collaborating on cutting-edge advancements in the field.

Read more

AMSBIO helps two young scientists to attend ISSCR 2023

AMSBIO, a provider of cutting-edge products and services for accelerating stem cell research, has sponsored two aspiring life scientists to attend and present posters at the recent ISSCR 2023 conference in Boston, USA. Whilst the original award was for one researcher, AMSBIO doubled the fund and awarded two grants based on the high quality of the entries.

Read more

Agility Life Sciences Announce Collaborative Services Agreement with Inaphaea BioLabs

One Nucleus Partner, Agility Life Sciences, has announced a collaborative services agreement with Inaphaea BioLabs. Claire Thompson, CEO of Agility, commented: "This will enable our clients to take the next steps in their development programmes by testing their prototype formulations in the Inaphaea cell based studies. We believe this will be beneficial to both companies as well as to our clients, creating a more comprehensive scientific environment, and accelerating development timelines."


Read more

Bruntwood SciTech receives planning approval for £60m specialist labs in Manchester Science Park's third masterplan phase

Progressive plans for the next phase of Manchester Science Park’s masterplan development have been approved by Manchester City Council. The scheme will see Bruntwood SciTech, a 50:50 joint venture between Bruntwood and Legal & General, deliver a £60m redevelopment of the Park’s existing Greenheys building, bringing forward 131,000 sq ft of highly specialist world-class lab space.

Read more

Pages